Security key
03828A101
KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (APLT)
CUSIP: 03828A101
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 19,276,965
- Total 13F value
- $15,634,509
- Share change
- -401,145
- Put/Call ratio
- 0%
- SEC-reported price per share
- $0.81
- Number of holders
- 34
- Value change
- -$232,317
- Number of buys
- 16
- Number of sells
- 17
- Shares outstanding
- 143,223,667
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
34
Top holders
10
APLT full security history
Ownership snapshot
Full 13F holder table
KalVista Pharmaceuticals, Inc. SEC filings
KalVista Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of APLT - KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRANKLIN TEMPLETON INC
Disclosed value leader
FRANKLIN TEMPLETON INC
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F
Highest disclosed value: $3,629,368
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FRANKLIN TEMPLETON INC has the largest disclosed position value at $3.63M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRANKLIN TEMPLETON INC's linked filing trail.
Disclosed position value
Top 5
FRANKLIN TEMPLETON INC
$3.63M
ORBIMED ADVISORS LLC
$2.32M
Knoll Capital Management, LLC
$1.86M
Alyeska Investment Group, L.P.
$963.7K
VANGUARD GROUP INC
$605.4K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRANKLIN TEMPLETON INC |
13F
Company
|
—
denominator unverified
|
$3,629,368
4,775,484 shares
|
— | 31 Dec 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$2,318,700
3,050,921 shares
|
— | 31 Dec 2022 |
| Knoll Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$1,862,000
2,450,000 shares
|
— | 31 Dec 2022 |
| Alyeska Investment Group, L.P. |
13F
Company
|
—
denominator unverified
|
$963,720
1,268,052 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$605,387
796,562 shares
|
— | 31 Dec 2022 |
| Point72 Asset Management, L.P. |
13F
Company
|
—
denominator unverified
|
$547,153
719,938 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
34
Shares
19,276,965
Rows available
34
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
34
Q1 2023 holders
34
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|